Rockwell Medical (RMTI) Reports Q4 Loss, Tops Revenue Estimates
Portfolio Pulse from
Rockwell Medical (RMTI) reported a Q4 loss of $0.02 per share, surpassing revenue estimates but missing the Zacks Consensus Estimate of $0.02 earnings per share. This is a decline from the $0.02 earnings per share reported a year ago.
March 20, 2025 | 12:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Rockwell Medical reported a Q4 loss of $0.02 per share, missing the Zacks Consensus Estimate but exceeding revenue expectations. This marks a decline from last year's $0.02 EPS.
The reported loss per share is below the Zacks Consensus Estimate, which is likely to negatively impact investor sentiment. However, the company did exceed revenue expectations, which may mitigate some negative impact. The decline from last year's earnings per share further adds to the negative outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100